Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity—Preliminary Study

Journal of Molecular Neuroscience

Volumn 56, Issue 1, 2015, Pages 154-163

  Kacperska, Magdalena Justyna ^a   Jastrzebski, Karol ^a   Tomasik, Bartlomiej ^a   Walenczak, Jakub ^a   Konarska Krol, Maria ^a   Glabinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Activation of the immune system; Biomarker; Central nervous system; EDSS; Expression analysis; miRNA 648a; miRNA 92a; miRNA let7a; Multiple sclerosis; Plasma

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS;

BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MULTIPLE SCLEROSIS;

EID: 84939971508     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0476-3     Document Type: Article

References (33)

1. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653–4662
2. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL (1997) Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A 94(2):599–603
3. Barnes MP, Kent RM, Semlyen JK, McMullen KM (2003) Spasticity in multiple sclerosis. Neurorehabil Neural Repair 17(1):66–70
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
5. Bohnsack MT, Czaplinski K, Gorlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10(2):185–191
6. Del Popolo G, Panariello G, Del Corso F, De Scisciolo G, Lombardi G (2008) Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29(4):S352–355
7. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the microprocessor complex. Nature 432(7014):231–235
8. Doi Y, Oki S, Ozawa T, Hohjoh H, Miyake S, Yamamura T (2008) Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A 105(24):8381–8386
9. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform 44(5):839–847
10. Fenoglio C, Ridolfi E, Galimberti D, Scarpini E (2012) MicroRNAs as active players in the pathogenesis of multiple sclerosis. Int J Mol Sci 13(10):13227–13239
11. Gandhi R, Healy B, Gholipour T et al (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729–740
12. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36(Database issue):D154–158
13. Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK (2012) miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol 248(1–2):32–39
14. Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ (2013) RISC in PD: the impact of microRNAs in Parkinson’s disease cellular and molecular pathogenesis. Front Mol Neurosci 6:40
15. Juntilla MM, Koretzky GA (2008) Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 116(2):104–110
16. Kappos L, Polman CH, Freedman MS et al (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67(7):1242–1249
17. Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A (2010) The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev 9(4):233–236
18. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610
19. Krupp LB, Coyle PK, Doscher C et al (1995) Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45(11):1956–1961
20. Kulakowska A, Bartosik-Psujek H, Hozejowski R, Mitosek-Szewczyk K, Drozdowski W, Stelmasiak Z (2010) Selected aspects of the epidemiology of multiple sclerosis in Poland—a multicentre pilot study. Neurol Neurochir Pol 44(5):443–452
21. Lehmann SM, Kruger C, Park B et al (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15(6):827–835
22. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907–911
23. Optic Neuritis Study Group (1997) The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 49(5):1404–1413
24. Reid G, Kirschner MB, van Zandwijk N (2011) Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 80(2):193–208
25. Roush S, Slack FJ (2008) The let-7 family of microRNAs. Trends Cell Biol 18(10):505–516
26. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2):199–208
27. Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219–6225
28. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683–747
29. Swaminathan S, Suzuki K, Seddiki N et al (2012) Differential regulation of the let-7 family of microRNAs in CD4+ T cells alters IL-10 expression. J Immunol 188(12):6238–6246
30. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD (2004) A protein sensor for siRNA asymmetry. Science 306(5700):1377–1380
31. Tsuchida A, Ohno S, Wu W et al (2011) miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102(12):2264–2271
32. Williams AE (2008) Functional aspects of animal microRNAs. Cell Mol Life Sci 65(4):545–562
33. Xiao C, Srinivasan L, Calado DP et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405–414